| sunitinib / Generic mfg. |
| Completed | 2 | 52 | Europe | Sunitinib-Malate | Johannes Gutenberg University Mainz, Pfizer | Gastric Adenocarcinoma, Barrett Esophagus | 07/09 | 08/09 | | |
| Completed | 2 | 28 | US | Sunitinib malate, Paclitaxel | Hoosier Cancer Research Network, Pfizer | Esophageal Cancer | 03/10 | 03/10 | | |
|
NCT00891878: Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction |
|
|
| Completed | 2 | 12 | US | capecitabine, sunitinib malate | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer | 01/13 | 01/13 | | |
NCT00702884: Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer |
|
|
| Completed | 2 | 25 | US | sunitinib malate, Sutent, SU011248 L-Malate salt, SU010398, PHA-290940AD, SU011248 | Tony Bekaii-Saab, Pfizer | Esophageal Cancer | 09/13 | 12/13 | | |
|
NCT00400114: Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer |
|
|
| Completed | 2 | 36 | Canada | Irinotecan, Cisplatin, Radiation, Surgery, sunitinib (Sutent) | University Health Network, Toronto, Pfizer | Esophageal Cancer | 09/16 | 09/16 | | |
